ceftriaxone
Selected indexed studies
- Efficacy of Ceftriaxone 1 g daily Versus 2 g daily for The Treatment of Community-Acquired Pneumonia: A Systematic Review with Meta-Analysis. (Expert Rev Anti Infect Ther, 2019) [PMID:31179786]
- Ceftriaxone and methicillin-susceptible staphylococcus aureus: a perspective from pharmacokinetics/pharmacodynamics studies. (Expert Opin Drug Metab Toxicol, 2021) [PMID:34225556]
- Ceftriaxone. (Indian Pediatr, 1990) [PMID:2210825]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy of Ceftriaxone 1 g daily Versus 2 g daily for The Treatment of Community-Acquired Pneumonia: A Systematic Review with Meta-Analysis. (2019) pubmed
- Ceftriaxone and methicillin-susceptible staphylococcus aureus: a perspective from pharmacokinetics/pharmacodynamics studies. (2021) pubmed
- Ceftriaxone. (1990) pubmed
- Ceftriaxone treatment of spondylodiscitis and other serious infections with Cutibacterium acnes. (2020) pubmed
- Ceftriaxone use for acute otitis media: Associated factors in a large U.S. primary care population. (2022) pubmed
- Ceftriaxone: a third-generation cephalosporin. (1985) pubmed
- Ceftriaxone penetration of tissues. (1988) pubmed
- Pharmacokinetics of ceftriaxone. (1991) pubmed
- An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea. (2025) pubmed
- Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections. (2002) pubmed